A very potent inhibitor of sEH (IC50 = 0.5 nM); displays high oral bioavailability for doses ranging from 0.01 to 1 mg/kg; with the COX-2 inhibitor celecoxib, suppresses tumor angiogenesis, inhibiting tumor growth and metastasis in a Lewis lung carcinoma model in mice.